248 related articles for article (PubMed ID: 22736280)
21. Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines.
Jia L; Wang S; Zhou H; Cao J; Hu Y; Zhang J
Int J Biochem Cell Biol; 2006; 38(9):1584-93. PubMed ID: 16702020
[TBL] [Abstract][Full Text] [Related]
22. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
[TBL] [Abstract][Full Text] [Related]
23. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
25. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
Isaji T; Kariya Y; Xu Q; Fukuda T; Taniguchi N; Gu J
Methods Enzymol; 2010; 480():445-59. PubMed ID: 20816221
[TBL] [Abstract][Full Text] [Related]
26. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
27. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
[TBL] [Abstract][Full Text] [Related]
28. Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions.
Zhang Y; Zhao JH; Zhang XY; Guo HB; Liu F; Chen HL
Mol Cell Biochem; 2004 May; 260(1-2):137-46. PubMed ID: 15228095
[TBL] [Abstract][Full Text] [Related]
29. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.
Kudo T; Nakagawa H; Takahashi M; Hamaguchi J; Kamiyama N; Yokoo H; Nakanishi K; Nakagawa T; Kamiyama T; Deguchi K; Nishimura S; Todo S
Mol Cancer; 2007 May; 6():32. PubMed ID: 17488527
[TBL] [Abstract][Full Text] [Related]
30. Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma.
Jin XL; Liu HB; Zhang Y; Wang BS; Chen HL
Glycoconj J; 2004; 20(6):399-406. PubMed ID: 15238704
[TBL] [Abstract][Full Text] [Related]
31. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
[TBL] [Abstract][Full Text] [Related]
32. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma.
Li JH; Huang W; Lin P; Wu B; Fu ZG; Shen HM; Jing L; Liu ZY; Zhou Y; Meng Y; Xu BQ; Chen ZN; Jiang JL
Sci Rep; 2016 Nov; 6():35210. PubMed ID: 27869218
[TBL] [Abstract][Full Text] [Related]
33. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
Chakraborty AK; Sousa Jde F; Chakraborty D; Funasaka Y; Bhattacharya M; Chatterjee A; Pawelek J
Gene; 2006 Jun; 374():166-73. PubMed ID: 16556489
[TBL] [Abstract][Full Text] [Related]
34. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.
Zhao Y; Nakagawa T; Itoh S; Inamori K; Isaji T; Kariya Y; Kondo A; Miyoshi E; Miyazaki K; Kawasaki N; Taniguchi N; Gu J
J Biol Chem; 2006 Oct; 281(43):32122-30. PubMed ID: 16940045
[TBL] [Abstract][Full Text] [Related]
35. Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro.
Jia L; Zhou H; Wang S; Cao J; Wei W; Zhang J
IUBMB Life; 2006 Apr; 58(4):209-16. PubMed ID: 16754299
[TBL] [Abstract][Full Text] [Related]
36. β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways.
Gao Y; Yang F; Su Z; He Z; Xiao J; Xu Y; Zha X; Xu F; Wang L
Biochem Biophys Res Commun; 2018 Oct; 505(2):569-577. PubMed ID: 30274773
[TBL] [Abstract][Full Text] [Related]
37. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation.
Huang W; Luo WJ; Zhu P; Tang J; Yu XL; Cui HY; Wang B; Zhang Y; Jiang JL; Chen ZN
Biochem J; 2013 Jan; 449(2):437-48. PubMed ID: 23005037
[TBL] [Abstract][Full Text] [Related]
38. High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma.
Niimi K; Yamamoto E; Fujiwara S; Shinjo K; Kotani T; Umezu T; Kajiyama H; Shibata K; Ino K; Kikkawa F
Br J Cancer; 2012 Dec; 107(12):1969-77. PubMed ID: 23169300
[TBL] [Abstract][Full Text] [Related]
39. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA.
Guo HB; Liu F; Chen HL
Biochem Biophys Res Commun; 1999 Oct; 264(2):509-17. PubMed ID: 10529394
[TBL] [Abstract][Full Text] [Related]
40. Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.
Lu J; Isaji T; Im S; Fukuda T; Kameyama A; Gu J
J Biol Chem; 2016 Mar; 291(11):5708-5720. PubMed ID: 26801611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
